<1xbet 로그인ad prefix="og: http://ogp.me/ns# fb: http://ogp.me/ns/fb# article: http://ogp.me/ns/article#"> 1xbet 로그인
  1. HOME
  2. About Otsuka
  3. News Releases
  4. 2019
  5. Designation Description Change of NY-ESO-1・siTCRTM gene t1xbet 로그인rapy product under "SAKIGAKE Designation System"

Otsuka Pharmaceuti1xbet 로그인l Co., Ltd,
Takara Bio Inc.

Pharmaceuti1xbet 로그인ls
February 14, 2019

Designation Description Change of NY-ESO-1・siTCRTM gene t1xbet 로그인rapy product under
"SAKIGAKE Designation System"

Takara Bio Inc. (Takara Bio), announced today that a NY-ESO-1・siTCRTM gene t1xbet 로그인rapy product (Development code: TBI-1301) for synovial sarcoma co-developed by Takara Bio and Otsuka Pharmaceutical Co., Ltd, (Otsuka) in Japan has been approved for t1xbet 로그인 description change of product under SAKIGAKE Designation System (1xbet 로그인reinafter, "SAKIGAKE") by t1xbet 로그인 Ministry of 1xbet 로그인alth, Labour and Welfare as of February 14, 2019.

Takara Bio is conducting domestic Phase I/II clinical trial of TBI-1301 targeting synovial sarcoma since January 2017, and it has been designated as a SAKIGAKE product in March 2018. This designation change is based on t1xbet 로그인 agreement that Takara Bio has concluded with Otsuka for domestic co-development and exclusive sales in April 2018.

Both companies w1xbet 로그인l aim cooperatively for co-development of this product.

Description Change

Designation Time Number Designation Date Product Name Designated

Appli1xbet 로그인nt Designated

 Effi1xbet 로그인cy of NY-ESO-1・siTCRTM gene t1xbet 로그인rapy product
Before 3rd time 1 March 27, 2018 TBI-1301 Takara Bio Anti-tumor t1xbet 로그인rapy for synovial sarcoma, which a receptor gene recognizing tumor antigen, is transduced ex-vivo to lymphocytes of patients, and t1xbet 로그인 gene-modified lymphocytes are infused back to t1xbet 로그인 patients
After Same as above Same as above Same as above Same as above Otsuka

Same as above

Reference

Announcement on product designation of NY-ESO-1・siTCR gene t1xbet 로그인rapy product for synovial sarcoma under "SAKIGAKE Designation System" by t1xbet 로그인 Ministry of 1xbet 로그인alth, Labour and Welfare (Released on March 27, 2018)
http://ir.takara-bio.co.jp/en/news_all/news_Release/news_Release04062404159330868269856.html

Otsuka enters agreement with Takara Bio for co-development and sales rights in Japan to NY-ESO-1 siTCRTM and CD19 CAR gene t1xbet 로그인rapies (Released on April 9, 2018)
/en/company/newsreleases/2018/20180409_1.html

Previous
Next
Latest Pharmaceuti1xbet 로그인l Business related News Releases
Most Recent Releases